Other
Other
Over 4 years (FY 2020 to FY 2024), Other shows a downward trend with a -100.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ3 2025
Last reportedQ1 2026
How to read this metric
Significant increases may indicate unexpected operational costs or changes in accounting accruals.
Detailed definition
This captures miscellaneous short-term obligations that do not fit into specific categories like accounts payable or acc...
Peer comparison
Varies widely by company; typically small relative to total current liabilities.
Metric ID:
other_other_sundry_liabilities_currentHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.33M | $5.63M | $6.65M | $0.00 | $877.00K | $2.09M | $8.07M | $1.44M | $1.42M | $0.00 | $1.42M | $97.00K | $0.00 | $26.00K |
| QoQ Change | — | +30.2% | +18.1% | -100.0% | — | +138.3% | +286.3% | -82.1% | -1.3% | -100.0% | — | -93.2% | -100.0% | — |
| YoY Change | — | — | — | — | -86.8% | — | — | — | +62.4% | -100.0% | -82.4% | -93.3% | — | — |
Range$0.00 – $8.07M
CAGR-79.3%
Avg YoY Growth-60.0%
Median YoY Growth-86.8%
Other at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other?
- Roivant Sciences (ROIV) reported other of $26.00K in Q4 2025.
- What is the long-term trend for Roivant Sciences's other?
- Over 4 years (2020 to 2024), Roivant Sciences's other has grown at a -100.0% compound annual growth rate (CAGR), from $3.04M to $0.00.
- What does other mean?
- Miscellaneous short-term debts or obligations not classified elsewhere.